Table 4.
Catalytic system | Substrate
|
||||
---|---|---|---|---|---|
8 | 9 | 10 | 11 | 12 | |
MycCI/MycCIIb | 0.97 ± 0.03 | 1.4 ± 0.1 | 0.96 ± 0.01 | 1.23 ± 0.05 | 1.11 ± 0.08 |
MycCI-RhFRED | 0.161 ± 0.008 | 1.19 ± 0.06 | 0.34 ± 0.01 | 0.81 ± 0.01 | 0.61 ± 0.02 |
TylHI/TylHIIb | N.D.c | N.D. | N.D. | N.D. | 0.14 ± 0.03 |
TylHI/MycCIIb | N.D. | N.D. | N.D. | N.D. | 1.63 ± 0.03 |
TylHI-RhFRED | N.D. | N.D. | N.D. | N.D. | 0.76 ± 0.02 |
MycCIS172A/MycCIIb | 1.15 ± 0.05 | 1.09 ± 0.05 | 0.96 ± 0.02 | 0.90 ± 0.03 | 0.86 ± 0.06 |
TOF = mol product/mol P450 per min. Product formation was monitored by HPLC over the first 30 min of the reaction (initial rates). Reported errors are standard deviations calculated from experiments performed in triplicate.
Includes MBP-FdR.
N.D. = value not determined.